COVID-19 vaccination in Morocco

Last updated

COVID-19 vaccination in Morocco
Date28 January 2021 – present
Location Morocco, Vaccination clinics
Cause COVID-19 pandemic
TargetImmunization against COVID-19
Organised by Ministry of Health (Morocco)
Participants45,249,522 total doses administered [1] [lower-alpha 1]
Outcome62.43% of the Moroccan population has received at least one dose of a vaccine
56.84% has been fully vaccinated

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Contents

The Ministry of Health has approved the following COVID-19 vaccines: Oxford–AstraZeneca, Sputnik V, and Sinopharm BIBP.

On 28 January 2021, Morocco launched a coronavirus vaccination campaign, a week after receiving its first shipment of the Oxford–AstraZeneca and Sinopharm BIBP vaccines. [2]

Background

The government has secured 66 million doses from different manufacturers such as AstraZeneca and Sinopharm. [2]

Local production

In July 2021, it was announced that the Moroccan pharmaceutical firm Sothema would start to locally produce 5 million doses of the Sinopharm BIBP vaccine per month. [3] [4]

Timeline

January 2021

In January, Morocco approved the following vaccines: Sputnik V, Sinopharm BIBP, and Oxford–AstraZeneca. [5]

On 22 January, the first batch of the Oxford–AstraZeneca vaccine, consisting of 2,000,000 doses, arrived in Morocco. [6]

On 27 January, the first batch of the Sinopharm BIBP vaccine, consisting of 500,000 doses, arrived in Morocco. [7]

February 2021

On 11 & 16 February, the second batches of the Oxford–AstraZeneca and Sinopharm BIBP vaccines, consisting of 4,500,000 doses, arrived in Morocco. [8] [9]

By the end of the month, 3.6 million vaccine doses had been administered.

March 2021

By the end of March, 7.6 million vaccine doses had been administered while 22% of the target population had been fully vaccinated.

April 2021

On 8 April, a batch of the Oxford–AstraZeneca vaccine, approximately 307,200 doses, arrived in Morocco from COVAX facility. [10]

On 26 & 30 April, two batches of the Sinopharm BIBP vaccine, consisting of 1,000,000 doses, arrived in Morocco. [11]

By the end of the month, 9 million vaccine doses had been administered while 28% of the target population had been fully vaccinated.

May 2021

On 15-16 May, a batch of the Oxford–AstraZeneca vaccine, approximately 650,000 doses, arrived in Morocco. [11]

On 19 & 23 May, two batches of the Sinopharm BIBP vaccine, consisting of 4,000,000 doses, arrived in Morocco. [11]

By the end of the month, 14 million vaccine doses had been administered while 35% of the target population had been fully vaccinated.

June 2021

In the first five months of the vaccination campaign, almost 10 million people received their first inoculation and 9.1 million were fully vaccinated. [12]

By the end of the month, 19 million vaccine doses had been administered while 59% of the target population had been fully vaccinated.

July 2021

On 13 & 17 July, two batches of 2,000,000 doses of the Sinopharm BIBP vaccine arrived in Morocco. [13] [14]

By the end of the month, 24 million vaccine doses had been administered while 68% of the target population had been fully vaccinated.

August 2021

By the end of August, 33 million vaccine doses had been administered while 88% of the target population had been fully vaccinated.

September 2021

By the end of September, 41 million vaccine doses had been administered and 19 million persons were fully vaccinated. The entire target population had been fully vaccinated by mid-September.

October 2021

By the end of October, 46 million vaccine doses had been administered and 22 million persons were fully vaccinated, exceeding the target population.

November 2021

By the end of November, 47 million vaccine doses had been administered and 23 million persons were fully vaccinated, exceeding the target population.

Vaccines

Morocco has received 7 million doses of the Oxford–AstraZeneca COVID-19 vaccine and 16.5 million doses of the Sinopharm BIBP vaccine.

Vaccines in order
VaccineApprovalDeploymentDoses ordered
Sinopharm BIBP Green check.svg YesGreen check.svg 28 January 202145 million
Oxford–AstraZeneca Green check.svg 6 January 2021Green check.svg 28 January 202120 million
Sputnik V Green check.svg 10 March 2021Dark Red x.svg No
Vaccines in trial stage
VaccineType (technology)Phase IPhase IIPhase III
Sinopharm WIBP InactivatedGreen check.svg CompletedGreen check.svg CompletedGreen check.svg Completed

Progress

Cumulative vaccinations in Morocco [15]

Priority groups

The vaccination campaign primarily targets health workers, security forces and people over 75, according to Moroccan authorities. [2]

Notes

  1. At least 23,333,590 of these have only been administered with the first dose, while 21,116,355 have been fully vaccinated and 799,577 have received a booster shot.

Related Research Articles

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

COVID-19 vaccination in Zimbabwe

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 5 December 2021, 3,874,694 people have received their first dose, and 2,884,045 people have received their second dose.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks fifth in the world and second in Asia.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 19 November 2021, 6,021,560 people have received their first dose a COVID-19 vaccine, and 3,369,628 people have received their second dose.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Nepal Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. "Vaccine Statistics: As of October 21, 2021". covidvax.live. Retrieved 22 October 2021.
  2. 1 2 3 AfricaNews (28 January 2021). "Morocco kicks off coronavirus vaccination drive". Africanews. Retrieved 7 March 2021.
  3. "Morocco's Sothema to produce China's Sinopharm vaccine". Zawya. 5 July 2021. Retrieved 22 July 2021.
  4. "Morocco seeks self-sufficiency, helping Africa through vaccine production". The Arab Weekly. 16 July 2021. Retrieved 23 July 2021.
  5. "Morocco – COVID19 Vaccine Tracker". covid19.trackvaccines. Retrieved 22 July 2021.
  6. "Morocco gets 2 million AstraZeneca vaccine doses, first big shipment to Africa". Reuters. 22 January 2021. Retrieved 22 July 2021.
  7. "Morocco receives 1st batch of Chinese Sinopharm COVID-19 vaccines". Xinhuanet. 28 January 2021. Retrieved 22 July 2021.
  8. "Morocco receives 4 million doses of AstraZeneca vaccine from India". Reuters. 11 February 2021. Retrieved 22 July 2021.
  9. "Morocco receives second batch of 500,000 Sinopharm doses". Reuters. 16 February 2021. Retrieved 22 July 2021.
  10. "COVID-19: Morocco Receives First Batch of COVAX Vaccines". Morocco World News. 9 April 2021. Retrieved 22 July 2021.
  11. 1 2 3 "Morocco Receives Additional 2 Million COVID-19 Vaccines from Beijing". Morocco World News. 24 May 2021. Retrieved 22 July 2021.
  12. "Covid: 776 nouveaux cas, 4 décès". L'Economiste (in French). 30 June 2021. Retrieved 9 July 2021.
  13. "Morocco receives 2 million doses of Chinese vaccine Sinopharm". Morocco Latest News. 13 July 2021. Retrieved 22 July 2021.
  14. "Sinopharm Delivers Two Million Doses of COVID-19 Vaccines to Morocco". Morocco World News. 17 July 2021. Retrieved 22 July 2021.
  15. "Vaccine Statistics: As of 16 August 2021". covidvax.live. Retrieved 22 July 2021.